Convulsive Status Epilepticus: Treatment
|
|
- Barrie O’Neal’
- 6 years ago
- Views:
Transcription
1 Chapter 117 Convulsive Status Epilepticus: Treatment JMK Murthy INTRODUCTION Status epilepticus (SE) refers to a condition in which there is a failure of the normal factors that serve to terminate typical seizures, 1 and is a common neurological emergency associated with high mortality and morbidity. It may be classified based solely on the presence or absence of convulsions, into convulsive SE (CSE) and nonconvulsive SE (NCSE). It requires emergent, targeted treatment to reduce the associated morbidity and mortality. The underlying etiology is the important determinant of mortality in SE. This review will discuss the evaluation and management of CSE. DEFINITION Traditionally, CSE has been defined as continuous seizure activity lasting 30 minutes or as two or more discrete seizures between which consciousness is not fully regained. 2 The new proposed operational definition for adults and older children (> 5-year-old) is a continuous, generalized, convulsive seizure lasting more than 5 minutes, or two or more seizures during which the patient does not return to baseline consciousness. 3 This new definition is based on the observations that spontaneous cessation of generalized convulsive seizures is unlikely after 5 minutes. 4,5 The exact definition of refractory SE (RSE) is unclear and the commonly used definition is seizure activity that continues after first- and second-line therapies have failed. 6 Most experts agree that patients should be considered in RSE after failure of adequately dosed initial benzodiazepine and one antiepileptic drug (AED). Duration of SE after initiation of treatment is no longer considered as a criterion for classification of RSE. 7 INCIDENCE In a systematic review, the reported incidence rates of CSE vary between 3.86 and 38 per 100,000 per year in children and 6 27 per 100,000 per year in adults. The incidence has a bimodal distribution with peaks in children aged less than a year, with per 100,000 and in the elderly, per 100, Estimates of the frequency of RSE in patients with SE have ranged from 31 to 44%. 9 There are no community based incidence studies in CSE from India. ETIOLOGY In adults, SE is more often of acute symptomatic etiology and the common etiologies include: central nervous system (CNS) infections, acute strokes, hypoxic encephalopathy, metabolic causes and low AED levels. No clear etiology can be identified in 20% of cases. 7,8,10-12 Of the acute symptomatic etiology, cerebrovascular disease is the predominant cause in developed countries, more so in the elderly. In India and other developing countries, CNS infections account for 28 67% of the etiological spectrum. 10,13 Determining the underlying etiology is very essential as it is an independent predictor of both mortality and morbidity. Mortality and Morbidity The reported mortality at hospital discharge in CSE is 9 21%, at 30 days: 19 27% and at 90 days: 19%. 21 The short-term mortality (all age groups) rates reported from India and other developing countries range between 10.5% and 28%. 10,13 Convulsive status epilepticus results in severe neurological or cognitive sequelae in 11 16% of patients. 14,22,23 Factors associated with poor outcome after generalized CSE include: underlying etiology, de novo development of SE in hospitalized patients, older age, impairment of consciousness, duration of seizures, focal neurological signs at onset and the presence of medical complications. 7 TREATMENT Repeated seizures cause an internalization of gamma (g)-aminobutyric acid (GABA A ) receptors, together with a movement of N-methyl-D-aspartate (NMDA) receptors to the synapse. This explains the time-dependent development of pharmacoresistance to GABAergic drugs. Gamma-aminobutyric acid (GABA A ) agonists with NMDA antagonists and with agents acting at other sites are successful in treating experimental SE, and in reducing SE-induced brain damage and epileptogenesis. 24 This basic knowledge suggests that the rational drug treatment in SE should aim at multiple receptors or ion channels to increase inhibition and simultaneously reduce excitation. For the patients with CSE, it is helpful to plan therapy (Flow chart 1) in a series of progressive stages. While selecting AEDs, the pharmacokinetics for use in SE is to be considered. These include ease of administration, onset of action (rapid), duration of action (intermediate to long), spectrum of activity (broad) and minimal morbidity. 25 Premonitory stage: Prolonged epileptic seizure (out-of-hospital) (5 minutes) First stage: Out-of or in-hospital (5 20 minutes) Second stage: Established SE (20 60 minutes) Third stage: Refractory status epilepticus (> 60 minutes). Treatment of CSE should occur rapidly and continue sequentially until clinical and electrographic seizures are halted. Critical care treatment and monitoring (Table 1) should be started simultaneously with emergent initial therapy and continued until further therapy is considered successful or futile. 7
2 Neurology Section 16 Flow chart 1: Convulsive status epilepticus (CSE): Treatment algorithm Abbreviations: IV, Intravenous; ceeg monitoring, Continuous electroencephalogram monitoring; Ig, Immunoglobulin TABLE 1 Status epilepticus: Monitoring and critical issues First stage (5 20 minutes): Oxygen supplement; obtain IV access, stabilize airway, respiration and hemodynamics as needed; monitor ECG and SpO 2 Thiamine 100 mg IV; 50 ml of 50% dextrose unless adequate glucose known. In children less than 2 years pyridoxine Investigations: Random blood glucose, LFT, RFT, electrolytes and BUN, toxicology screening, magnesium, phosphorous, CSF if CNS infection a diagnostic possibility, and CT/MRI Second stage or established GCSE (20 60 minutes): Cardiorespiratory function monitoring: ECG, blood pressure, SpO 2 ; Pressors if needed, identify and treat medical complications, treat acidosis Investigations: ceeg monitoring, if the facilities are available Refractory status epilepticus (> 60 minutes): Shift to ICU with facility for hemodynamic monitoring and ceeg monitoring, identification and treatment of medical complications including hyperthermia Consider treating acidosis if ph is 7.2 or if symptomatic Abbreviations: IV, Intravenous; ECG, Electrocardiogram; SpO 2, Pulse oximeter oxygen saturation; LFT, Liver function tests; RFT, Renal function tests; BUN, Blood urea nitrogen; CSF, Cerebrospinal fluid; CNS, Central nervous system; CT, Computed tomography; MRI, Magnetic resonance imaging; GCSE, Generalized convulsive status epilepticus; EEG, Electroencephalogram; ceeg, Continuous electroencephalography; ICU, Intensive care unit 534 Continuous Electroencephalography Monitoring in Status Epilepticus Treatment of SE in the intensive care units (ICUs) usually requires continuous electroencephalography (ceeg) monitoring to direct treatment. It should be initiated within 1 hour of SE onset, if ongoing seizures are suspected. It is suggested to use maintenance AEDs and monitor for recurrent seizures by ceeg monitoring during titration period. If the patient is being treated for RSE at a facility without ceeg capabilities, consider for transfer to a facility with ceeg monitoring. The indications for ceeg monitoring in SE are: recent clinical seizure or SE without return to baseline more than 10 minutes; coma, including postcardiac arrest; epileptiform activity or periodic discharges on initial 30 minutes EEG; and suspected nonconvulsive seizures in patients with altered mental status. Duration of ceeg monitoring should be at least 48 hours in comatose patients to evaluate for nonconvulsive seizures. The treatment endpoints for ceeg monitoring are: cessation of nonconvulsive seizures; diffuse beta activity; burst suppression 8 20 seconds intervals; and complete suppression of electroencephalography (EEG). 7 Premonitory Stage (5 Minutes) Benzodiazepines are the drug of choice for out-of-hospital treatment. Lorazepam is the drug of choice for intravenous (IV) administration, and midazolam for intramuscular (IM) administration Rectal diazepam has been shown to be effective in children. 26 Other options, both in children and adults include buccal midazolam 27 and intranasal midazolam Prehospital treatment of SE (PHTSE) trial showed a clear benefit of active treatment with either diazepam or lorazepam over placebo, with a trend favoring lorazepam over diazepam. 28 First Stage/Out-of or In-hospital (5 20 Minutes) The veteran affairs (VA) cooperative study demonstrated advantage of IV treatment with lorazepam over phenytoin. However, there were
3 Section 16 Chapter 117 Convulsive Status Epilepticus: Treatment no significant differences among the other agents, phenobarbital and diazepam/phenytoin. 18,32 Prehospital treatment of SE trial demonstrated a clear benefit of active treatment with lorazepam in terminating generalized CSE. 28 Benzodiazepines, lorazepam and diazepam are effective in terminating seizures in 59 78% of patients. 18,28 Second Stage or Established Convulsive Status Epilepticus (20 60 Minutes) When benzodiazepines fail to terminate CSE, a second-line drug, IV phenytoin/fosphenytoin, phenobarbate or valproate sodium, is considered. 2,7,10,13,18,33-35 Fosphenytoin is preferred to phenytoin because of its water solubility and neutral ph, thereby allowing more rapid administration with less adverse effects and its compatibility with all IV fluids. Valproate sodium has been shown to be as effective as phenytoin/fosphenytoin in terminating SE in patients who have previously failed with benzodiazepines 34,35 as first-line treatment. 15 It would be the best choice in patients with a history of primary generalized epilepsy. Refractory Status Epilepticus (> 60 Minutes) Till date, no randomized controlled trials have been done in RSE. Most experience is with continuous infusion (civ) of anesthetic agents: phenobarbital, midazolam and propofol. 8,9,36,37 No difference was found in mortality among the groups treated with these agents. 33 Pentobarbital was associated with a lower frequency of acute treatment failures and breakthrough seizures. Superior pharmacokinetics and favorable adverse effect profile makes propofol preferred drug in RSE in both adults and children. 37,38 Refractory status epilepticus was successfully treated with propofol in about two-thirds of patients. Midazolam is an effective, shortacting benzodiazepine that when given as an infusion has an efficacy in RSE. 36,39 As pentobarbital is not freely available in India, thiopental can be used. Dosing of civ anesthetic agents for RSE should be titrated to cessation of electrographic seizures or burst suppression. A period of hours of electrographic control by ceeg monitoring is recommended prior to slow withdrawal of civ anesthetic agents for RSE. Use of civ anesthetic agents frequently requires assisted ventilation and cardiovascular monitoring. Vasopressor agents may also be required to overcome hypotension and cardiopulmonary depression related to these agents. Newer Antiepileptic Drugs Newer AEDs have better safety profile and minimal pharmacokinetic interactions with other comedications, which are invariable in patients with critical illness and SE. Though the use of newer AEDs in the treatment of RSE has not been studied systematically, there is cumulative data of their efficacy in both SE and RSE. Three adult reports totaling 10 patients described control of RSE with nasogastric topiramate. 40,41 Levetiracetam has a different mechanism of action compared to all other AEDs, and may be associated with cellular targets, synaptic vesicular protein 2A (SV2A). Studies using IV levetiracetam in SE, NCSE and RSE in children, adults and elderly suggest the efficacy and safety of the drug In four studies, all from Germany, treatment with IV levetiracetam showed an overall response in two out of three patients with SE A retrospective study suggests that IV levetiracetam might be an alterative treatment of SE, especially in elderly patients with vascular SE and concomitant medical condition. 52 Its efficacy has also been proved in RSE in patients with brain tumors. 53 In a comparative study of phenytoin, valproate and levetiracetam as second-line drugs in SE, even without significant differences on outcome at discharge, levetiracetam seems less efficient than valproate to control SE after benzodiazepine. 54 Lacosamide is a novel anticonvulsant drug that acts by slow inactivation of the voltage-gated sodium channel, and is available as infusion. Case reports suggest that lacosamide may have a role in SE. However, the data are weakened by the heterogeneity of the reports, descriptive nature and the common divergence from the current recommendations for the treatment of SE. 55 In the study by Hofler et al., 56 success rate in patients with SE receiving lacosamide as first or second drug was 100% (8 of 8), as third drug 81% (11 of 15) and as fourth or later drug was 75% (6 of 8). A retrospective multicenter case series reports administration of IV lacosamide in 39 patients with predominantly partial forms of SE after failure of standard treatment. Lacosamide was the last anticonvulsant in 17 patients, suggesting a success rate of 44%. 57 Albers and colleagues 58 reported termination of SE with lacosamide in seven patients who were unsuccessfully treated with other AEDs before lacosamide. In a recent study, nine patients received lacosamide after failure of at least two other agents, none of them responded to lacosamide according to the predefined criteria. 59 Intravenous levetiracetam seems an efficient and safe AED after failure of benzodiazepines in SE and RSE and IV lacosamide may become a reasonable adjunct in SE, but further clinical experience is required. 60 Emerging Therapies in Refractory Status Epilepticus In most patients, the above suggested treatment regimens are sufficient to control the seizures. If the seizures persist even after 24 hours in spite of institution of the above treatment protocols, other treatment strategies may be required to terminate the status. This stage is considered to be super-rse. Super-RSE is defined as SE that continues or recurs 24 hours or more after the onset of anesthetic therapy, including those cases that recur on the reduction or withdrawal of anesthesia. 61 Inhalational Anesthetic Agents Inhalational anesthetic agents (IAs), isoflurane and desflurane are an alternative approach to the treatment of RSE. Their attractive features include efficacy, rapid onset of action and the ability to titrate the dose according to the effects demonstrated on the EEG. Isoflurane and desflurane in endtidal concentrations of 1.2 5% achieved an EEG burst suppression and termination of seizure activity within minutes. 62,63 However, further studies are needed in this field. Ketamine N-methyl-D-aspartate receptor antagonists are candidate drugs for SE that is refractory to drugs modulating GABA receptors. Ketamine is an NMDA receptor antagonist. An experimental study has demonstrated synergistic action of diazepam and ketamine in terminating SE, and suggested that this combination might be a clinically useful therapeutic option for RSE. 64,65 The efficacy of ketamine in extremely RSE has been documented both in adults and children. 65,66 It has no cardiac depressant properties, and does not cause hypotension. Steroids and Immunotherapy The rationale for the use of steroids and immunotherapy include: the recognition that RSE may be due to antibodies directed against neural elements; increasing recognition of the role of inflammation in epileptogenesis; and SE may be the initial presenting feature of some of the immune-mediated encephalopathies. 65 Nonpharmacological Treatments These include resective surgery, ketogenic diet, vagal nerve stimulation, hypothermia and electroconvulsive therapy. Neurosurgical interventions can be an option in patients with extremely RSE if a 535
4 Neurology Section focal area of ictal onset can be identified. 65 Three series including 20 children with RSE reported successful RSE termination following neurosurgical interventions. 65 Maintenance Treatment In parallel with emergency treatment, attention must be given to maintenance AED therapy to prevent recurrence of seizures. In patients known to have epilepsy, their usual AEDs should be maintained and dose adjustments made depending on AED levels. In patients presenting de novo, the AEDs, phenytoin/fosphenytoin or valproic acid, used to control the status can in principle be continued as oral maintenance therapy. In others, unless relatively short-lived treatment is anticipated, the preference is to initiate oral maintenance therapy with valproic acid or carbamazepine or any of the newer AEDs topiramate or levetiracetam at standard doses. 67,68 REFERENCES 1. Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia. 1999;40(Suppl 1):S Epilepsy Foundation of America s Working Group on status Epilepticus: Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America s Working Group on Status Epilepticus. JAMA. 1993;270(7): Lowenstein DH, Bleck T, Macdonald RL. It s time to revise the definition of status epilepticus. Epilepsia. 1999;40: Theodore WH, Porter RJ, Albert P, et al. The secondarily generalized tonic-clonic seizure: a videotape analysis. Neurology. 1994;44(8): Shinnar S, Berg AT, Moshe SL, et al. How long do new-onset seizures in children last? Ann Neurol. 2001;49(5): Shorvon S. Definition, classification and frequency of status epilepticus. In Shorvon S (Ed): Status Epilepticus: Its Clinical Features and Treatment in Children and Adults. Cambridge: Cambridge University Press; pp Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3-23. doi /s z. 8. Chin RFM, Neville BGR, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol. 2004;11(12): Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2006;62(11): Murthy JMK, Jayalaxmi SS, Kanikannan MA. Convulsive status epilepticus: clinical profile in a developing country. Epilepsia. 2007;48(12): Epub DeLorenzo RJ, Pellock JM, Towne AR, et al. Epidemiology of status epilepticus. J Clin Neurophysiol. 1995;12(4): Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993;43(3 Pt 1): Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology. 2006;67(2): Alldredge BK. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345(9): Claassen J, Lokin JK, Fitzsimmons BF, et al. Predictors of functional disability and mortality after status epilepticus. Neurology. 2002;58(1): Rossetti AO, Hurwitz S, Logroscino G, et al. Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry. 2006;77(5): Novy J, Rossetti AO. Oral pregabalin as an add-on treatment for status epilepticus. Epilepsia. 2010;51(10): Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339(12): Logroscino G, Hesdorffer DC, Cascino G, et al. Short-term mortality after a first episode of status epilepticus. Epilepsia. 1997;38(12): Legriel S, Mourvillier B, Bele N, et al. Outcomes in 140 critically ill patients with status epilepticus. Intensive Care Med. 2008;34(3): Epub Legriel S. Functional outcome after convulsive status epilepticus. Crit Care Med. 2010;38: Oxbury JM. Causes and consequences of status epilepticus in adults; a study of 86 cases. Brain 1971;94: Aminoff MJ, Simon RP. Status epilepticus: causes, clinical features and consequences in 98 patients. Am J Med 1980;69: Wasterlain GC, Chen JWY. Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia. 2008;49(Suppl. 9): Wheless JW, Treiman DM. The role of the newer antiplatelet drugs in the treatment of generalized convulsive status epilepticus. Epilepsia 2008;49 (Suppl. 9): Dreifuss FE, Rosman NP, Cloyd JC et al. A comparison of rectal diazepam fel and placebo for acute repetitive seizures. N Engl J Med. 1998;338: Scott RC, Besag FMC, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomized trial. Lancet. 1999;353: Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital statue epilepticus. N Engl J Med. 2001;345: McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomized controlled trial. Lancet. 2005;366: Bhattacharyya M, Kalra V, Gulati S. Intranasal midazolam vs rectal diazepam in acute childhood seizures. Pediatr Neurol. 2006;34: Harbord MG, Kyrkou NE, Kyrkou MR, Kay D, Coulthard KP. Use of intranasal midazolam to treat acute seizures in pediatric community settings. J Paediatr Child Health. 2004;40: Kalviainen R. Status epilepticus treatment guidelines. Epilepsia 2007;48: Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med. 1998;338; Larch J, Trinka E. Intravenous valproate in status epilepticus: a systematic review of the evidence. Epilepsia. 2006;47[s3], Trinka E. The use of valproate and new antiepileptic drugs in status epilepticus. Epilepsia. 2007;48(Suppl. 8): Claassen J, Hirsch LJ, Emerson RC, et al. Treatment of refractory status epilepticus with pentobabrbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;41: Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia. 2005;45: van Gestel JPJ, Blusse van Oud-Alblas HJ, Malingre M, Ververs FFT, Braun KPJ, van Nieuwenhuizen O. Propofol and thiopental for refractory status epilepticus in children. Neurology. 2005;65: Gilbert DL, Gartside PS, Glauser TA. Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: a meta-analysis. J Child Neurol. 1999;14: Bensalem MK, Fakhoury TA. Topiramate and status epilepticus: Reoprt of three cases. Epilepsy Behav. 2003;4: Towne AR, Garnett LK, Waterhouse EJ, Morton LD, De Lorenzo RJ. The use of topiramate in refractory status epilepticus. Neurology. 2003;60: Rupprecht S, Franke K, Fitzek S, Witte OW, Hagemann G. Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res. 2007;73: Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN. The use of levetiracetam in refractory status epilepticus. Seizure. 2006;15: Rossetti AO, Bromfield EB. Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav. 2006;8: Trabacca A, Profice P, Costanza MC, Gesualdi M, De Rinaldis M. Levetiracetam in non-convulsive status epilepticus in childhood: a case report. J Child Neurol. 2007;22: Fattouch J, Di Bonaventura C, Casciato S, et al. Intravenous levetiracetam as first-line treatment of status epilepticus in the elderly. Acta Neurol Scand. 2010;121: Tripathi M, Vibha D, Choudhary N, et al. Management of refractory status epilepticus at a tertiary care centre in a developing country. Seizure. 2010;19: Knake S, Gruener J, Hattemer K, et al. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry. 2008;79:588-9.
5 Section 16 Chapter 117 Convulsive Status Epilepticus: Treatment 49. Eue S, Grumbt M, Muller M, Schulze A. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam. Epilepsy Behav. 2009;15: Moddel G, Bunten S, Dobis C, et al. Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus. J Neurol Neurosurg Psychiatry. 2009;80: Berning S, Boesebeck F, van Baalen A, Kellinghaus C. Intravenous levetiracetam as treatment for status epilepticus. J Neurol. 2009;256: Gámez-Leyva G, Aristín JL, Fernández E, Pascual J. Experience with intravenous levetiracetam in status epilepticus: a retrospective case series. CNS Drugs. 2009;23: Swisher CB, Doreswamy M, Gingrich KJ, Vredenburgh JJ, Kolls BJ. Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors. Neurocrit Care. 2011;16: Alvarez V, Januel JM, Burnand B, Rossetti AO. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia. 2011;52: Fernandez EM, Franck AJ. Lacosamide for the treatment of refractory status epilepticus. Ann Pharmacother aph.1q461: published ahead of print October 18, Hofler J, Unterberger I, Dobesberger J, Kuchukhidze G, Walser G, Trinka E. Intravenous lacosamide in status epilepticus and seizure disorders. Epilepsia. 2011;52:e Kellinghaus C, Berning S, Immisch I, Larch J, Rosenow F, Rossetti AO, Tilz C, Trinka E. Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand. 2011;123: Albers JM, Moddel G, Dittrich R, Steidl C, Suntrup S, Ringelstein EB, Dziewas R. Intravenous lacosamide: an effective add-on treatment of refractory status epilepticus. Seizure. 2011;20: Goodwin H, Hinson HE, Shermock KM, Karanjia N, Lewin JJ 3rd. The use of lacosamide in refractory status epilepticus. Neurocrit Care. 2011;14: Holtkamp M. Treatment strategies for refractory status epilepticus. Curr Opin Crit Care. 2011;17: Shorvon SD, Trinka E. Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation. Epilepsia. 2011;52 (Suppl 8): Sakaki T, Abe K, Hoshida T, et al. Isoflurane in the management of status epilepticus after surgery for lesion around the motor area. Acta Neurochir (Wien). 1992;116: Mirsattari SM, Sharpe MD, Young B. Treatment of refractory status epilepticus with inhalational anesthetic agents: iso flurane and desfluranm. Arch Neurol. 2004;61: Martin BS, Kapur J. A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation. Epilepsia. 2008;49: Shorvon M, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134: Bleck TP. Refractory status epilepticus. Curr Opin Crit Care. 2005;11: Jackson MJ. Choice of antiepileptic drug which one to try first and what to do if it fails. Practical Neurol. 2005;5: Kelviainen V, Eriksson K, Parviainen I. Refractory generalized convulsive status epilepticus: a guide to treatment. CNS Drugs. 2005;19:
Refractory Status Epilepticus in Children: What are the Options?
Refractory Status Epilepticus in Children: What are the Options? Weng Man Lam, PharmD, BCPS, BCPPS PICU Clinical Pharmacy Specialist Memorial Hermann Texas Medical Center November 11, 2017 Objectives 1.
More informationThe Management of Refractory Status Epilepticus: An Update
Epilepsia, 47(Suppl. 1):35 40, 2006 Blackwell Publishing, Inc. C International League Against Epilepsy The Management of Refractory Status Epilepticus: An Update Daniel H. Lowenstein Department of Neurology,
More informationStatus Epilepticus. Ednea Simon, MD Swedish Pediatric Neuroscience Center
Status Epilepticus Ednea Simon, MD Swedish Pediatric Neuroscience Center 1 Status Epilepticus Status epilepticus (SE) is a condition resulting either from failure of the mechanisms responsible for seizure
More informationLieven Lagae Department of Paediatric Neurology Leuven University Leuven, Belgium. Management of acute seizure settings from infancy to adolescence
Lieven Lagae Department of Paediatric Neurology Leuven University Leuven, Belgium Management of acute seizure settings from infancy to adolescence Consequences of prolonged seizures Acute morbidity and
More informationA.T. Prabhakar, MBBS, MD, DM. Dept. of Neurological sciences, Christian Medical College, Vellore
A.T. Prabhakar, MBBS, MD, DM. Dept. of Neurological sciences, Christian Medical College, Vellore Abstract Status epilepticus is defined as a continuous, generalized, convulsive seizure lasting more than
More informationPhenytoin, Levetiracetam, and Pregabalin in the Acute Management of Refractory Status Epilepticus in Patients with Brain Tumors
Neurocrit Care (2012) 16:109 113 DOI 10.1007/s12028-011-9626-4 ORIGINAL ARTICLE Phenytoin, Levetiracetam, and Pregabalin in the Acute Management of Refractory Status Epilepticus in Patients with Brain
More informationStatus Epilepticus: Implications Outside the Neuro-ICU
Status Epilepticus: Implications Outside the Neuro-ICU Jeffrey M Singh MD Critical Care and Neurocritical Care Toronto Western Hospital October 31 st, 2014 Disclosures I (unfortunately) have no disclosures
More informationA. LeBron Paige, M.D. Director, Epilepsy Program UT Erlanger Neurology
A. LeBron Paige, M.D. Director, Epilepsy Program UT Erlanger Neurology Acute NeuroCare Symposium & Expo 10/20/2017 Conflict of Interest Statement Conflict of Interest Declaration: I am a paid consultant
More informationSAGE-547 for super-refractory status epilepticus
NIHR Innovation Observatory Evidence Briefing: April 2017 SAGE-547 for super-refractory status epilepticus NIHRIO (HSRIC) ID: 10866 NICE ID: 8456 Status epilepticus is a single epileptic seizure lasting
More informationStop the Status: Improving Outcomes in Pediatric Epilepsy Syndromes. Michelle Welborn, PharmD ICE Alliance
Stop the Status: Improving Outcomes in Pediatric Epilepsy Syndromes Michelle Welborn, PharmD ICE Alliance Overview Seizures and Epilepsy Syndromes Seizure Emergencies Febrile Seizures Critical Population
More informationStatus Epilepticus: A refresher. Objectives
Status Epilepticus: A refresher Ruben D. Villanueva, Pharm.D., BCPS OU Medical Center Trauma ICU Pharmacist Objectives Define seizures, convulsive and non convulsive status epilepticus, and refractory
More informationEpilepsy CASE 1 Localization Differential Diagnosis
2 Epilepsy CASE 1 A 32-year-old man was observed to suddenly become unresponsive followed by four episodes of generalized tonic-clonic convulsions of the upper and lower extremities while at work. Each
More informationRefractory status epilepticus
Neurology Asia 2013; 18 (Supplement 1) : 67 71 Refractory status epilepticus Ankit Singhal, Manjari Tripathi Department of Neurology, All India Institute of Medical Sciences (AIIMS), New Delhi, India Abstract
More informationTreatment of Status Epilepticus SUDA JIRASAKULDEJ, MD KING CHULALONGKORN MEMORIAL HOSPITAL AUGUST 21, 2016
Treatment of Status Epilepticus SUDA JIRASAKULDEJ, MD KING CHULALONGKORN MEMORIAL HOSPITAL AUGUST 21, 2016 Outline Definition of status epilepticus Classification of status epilepticus Treatment of status
More informationCHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island
#CHAIR2014 7TH ANNUAL CHAIR SUMMIT Master Class for Neuroscience Professional Development September 11 13, 2014 Westin Tampa Harbour Island Sponsored by #CHAIR2014 Clinical Case Challenge: Seizure Emergency
More informationStatus Epilepticus And Prolonged Seizures: Guideline For Management In Adults. Contents
Status Epilepticus And Prolonged Seizures: Guideline For Management In Adults Classification: Clinical guideline Lead Author: Rajiv Mohanraj, Consultant Neurologist Additional author(s): Matt Jones, Consultant
More informationSupplementary Online Content
Supplementary Online Content Hocker SE, Britton JW, Mandrekar JN, Wijdicks EFM, Rabinstein AA. Predictors of outcome in refractory status epilepticus. Arch Neurol. Published online October 8, 2012. doi:10.1001/archneurol.2012.1697.
More informationElectroencephalography. Role of EEG in NCSE. Continuous EEG in ICU 25/05/59. EEG pattern in status epilepticus
EEG: ICU monitoring & 2 interesting cases Electroencephalography Techniques Paper EEG digital video electroencephalography Dr. Pasiri Sithinamsuwan PMK Hospital Routine EEG long term monitoring Continuous
More informationStatus Epilepticus. G. Bryan Young, MD, FRCPC. Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada
1 Status Epilepticus G. Bryan Young, MD, FRCPC Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada Contact information: Dr. G. B. Young, Room B10-106, University
More informationIs pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study
Pugin et al. Critical Care 2014, 18:R103 RESEARCH Open Access Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study Deborah Pugin 1, Brandon Foreman
More information8/27/2017. Super-Refractory Status Epilepticus 2014 Pediatric Chula Experience. Definition SE. Definition SE. Epidemiology CSE. Classification of SE
Super-Refractory Status Epilepticus 2014 Pediatric Chula Experience Definition SE Traditional : Prolonged seizure lasting 30 mins or series of seizure without full recovery to baseline lasting 30 mins
More informationDuration of refractory status epilepticus and outcome: Loss of prognostic utility after several hours
FULL-LENGTH ORIGINAL RESEARCH Duration of refractory status epilepticus and outcome: Loss of prognostic utility after several hours *Frank W. Drislane, yandrew S. Blum, zmaria R. Lopez, xshiva Gautam,
More informationNonConvulsive Seizure
Sample Protocol #5: Management of status epilepticus and seizures in hospitalized patients nconvulsive Seizure Patient presents with alteration of consciousness unexplained by other etiologies AND suspicious
More informationTreatment adherence and outcomes in the management of convulsive status epilepticus in the emergency room
Original article Epileptic Disord 2007; 9 (1): 43-50 Treatment adherence and outcomes in the management of convulsive status epilepticus in the emergency room Taim Muayqil, Brian H. Rowe, S. Nizam Ahmed
More informationAPPENDIX K Pharmacological Management
1 2 3 4 APPENDIX K Pharmacological Management Table 1 AED options by seizure type Table 1 AED options by seizure type Seizure type First-line AEDs Adjunctive AEDs Generalised tonic clonic Lamotrigine Oxcarbazepine
More informationStatus epilepticus: news and perspectives
Status epilepticus: news and perspectives LOREDANA LUCA MD, PHD EMERGENCY COUNTY HOSPITAL PIUS BRINZEU CLINIC OF ANAESTHESIA AND INTENSIVE CARE TIMISOARA, ROMANIA Objectives History Definition of status
More informationAuthor Manuscript Faculty of Biology and Medicine Publication
Serveur Académique Lausannois SERVAL serval.unil.ch Author Manuscript Faculty of Biology and Medicine Publication This paper has been peer-reviewed but dos not include the final publisher proof-corrections
More information11/1/2018 STATUS EPILEPTICUS DISCLOSURE SPEAKER FOR SUNOVION AND UCB PHARMACEUTICALS. November is National Epilepsy Awareness Month
STATUS EPILEPTICUS ALBERTO PINZON, MD, MSBE, PhD November is National Epilepsy Awareness Month DISCLOSURE SPEAKER FOR SUNOVION AND UCB PHARMACEUTICALS 1 SEIZURE A transient occurrence of signs and/or symptoms
More informationPrescribing and Monitoring Anti-Epileptic Drugs
Prescribing and Monitoring Anti-Epileptic Drugs Mark Granner, MD Clinical Professor and Vice Chair for Clinical Programs Director, Iowa Comprehensive Epilepsy Program Department of Neurology University
More informationCan t Stop the Seizing!
Can t Stop the Seizing! Joseph Miller, MD, MS MCEP Critical Care March, 2019 Objectives Describe the importance of time to treatment Delineate treatment based on best evidence Describe novel diagnostic
More informationICU EEG MONITORING: WHY, WHEN AND FOR WHOM
ICU EEG MONITORING: WHY, WHEN AND FOR WHOM Aatif M. Husain, MD Duke University Veterans Affairs Medical Center Durham, NC In the last two decades much has been learned about the frequency with which seizures
More informationGuidelines for the Evaluation and Management of Status Epilepticus
Guidelines for the Evaluation and Management of Status Epilepticus Gretchen M. Brophy, Rodney Bell, Jan Claassen, Brian Alldredge, Thomas P. Bleck, Tracy Glauser, Suzette M. LaRoche, James J. Riviello,
More informationEmergency Management of Paediatric Status Epilepticus. Dr. Maggie Yau Department of Paediatrics Prince of Wales Hospital
Emergency Management of Paediatric Status Epilepticus Dr. Maggie Yau Department of Paediatrics Prince of Wales Hospital Definition (ILAE 2015) After t1 failure of the mechanisms responsible for seizure
More informationCrackCast Episode 18 Seizures
CrackCast Episode 18 Seizures Episode overview: 1) Define status epilepticus 2) List the doses of common medications used for status epilepticus 3) List 10 differential diagnoses for seizures 4) List 10
More informationManagement of acute seizure and status epilepticus. Apisit Boongird, MD Division of Neurology Ramathibodi hospital
Management of acute seizure and status epilepticus Apisit Boongird, MD Division of Neurology Ramathibodi hospital Outlines Seizure cluster/ Acute repetitive seizures Status epilepticus Seizure cluster
More informationContinuous EEG: A Standard in Canada?
Continuous EEG: A Standard in Canada? Victoria McCredie MBChB Neurointensivist Sunnybrook Health Sciences Centre Critical Care Canada Forum 28 th October 2015 No conflicts of interest to disclose. Outline
More informationIntravenous levetiracetam treatment in Thai adults with status epilepticus
Neurology Asia 2013; 18(2) : 167 175 Intravenous levetiracetam treatment in Thai adults with status epilepticus 1 Suwaporn Thongplew, 2 Sriwatree Chawsamtong, 1 Kittisak Sawanyawisuth, 1,3 Somsak Tiamkao,
More informationClinical Study Refractory Status Epilepticus: Experience in a Neurological Intensive Care Unit
Journal of Critical Care Medicine, Article ID 821462, 9 pages http://dx.doi.org/10.1155/2014/821462 Clinical Study Refractory Status Epilepticus: Experience in a Neurological Intensive Care Unit O. H.
More informationSuccessful treatment of super-refractory tonic status epilepticus with rufinamide: first clinical report
*Manuscript Click here to view linked References Successful treatment of super-refractory tonic status epilepticus with rufinamide: first clinical report Thompson AGB 1, Cock HR 1,2. 1 St George s University
More informationNMDOH digital library; keywords searched: pre-hospital, benzodiazepine, emergency medical technician, treatment of seizures, status epilepticus.
Background Literature Review and Recommendations Administration of Benzodiazepines by EMT -I in the pre-hospital setting EMS Bureau Protocol Review Steering Committee Status epilepticus is a recognized
More informationFirst Line Therapy in Acute Seizure Management. William Dalsey, MD, FACEP
First Line Therapy in Acute Seizure Management Case Presentation A 32-year old male intravenous drug user was brought to the ED having had a witnessed generalized tonic-clonic seizure 10 minutes prior
More informationSeizures Emergency Treatment
Seizures Emergency Treatment Emergency Seizures SEIZURE CLASSIFICATION Cluster seizures - 2 or more generalized convulsive seizures in 24 hours Simon R. Platt BVM&S MRCVS Dipl. ACVIM (Neurology) Dipl.ECVN
More informationHigh-dose midazolam infusion for refractory status epilepticus
High-dose midazolam infusion for refractory status epilepticus Andres Fernandez, MD Hector Lantigua, MD Christine Lesch, PharmD Belinda Shao, BA Brandon Foreman, MD J. Michael Schmidt, PhD Lawrence J.
More information8/27/2017. Management of Status Epilepticus & Super-Refractory SE Definition SE. Definition SE. Epidemiology CSE. Classification of SE
Management of Status Epilepticus & Super-Refractory SE 2017 TAYARD DESUDCHIT MD. HEAD, DIV. OF PED. NEUROLOGY FACULTY OF MEDICINE CHULALONGKORN U. Definition SE Traditional : Prolonged seizure lasting
More informationManagement of acute seizure and status epilepticus
Management of acute seizure and status epilepticus Apisit Boongird, MD Division of Neurology Ramathibodi Hospital Sunday August 27 10.00-10.45 Bangsan Objectives Acute repetitive seizure Status epilepticus
More informationStatus epilepticus. Dr FL Chow
Status epilepticus Dr FL Chow Terms Seizure paroxysmal event due to abnormal excessive neuronal activity in brain Epilepsy recurrent seizures due to chronic, underlying process; epilepsy syndromes Classification
More informationTalk outline. Some definitions. Emergency epilepsy now what? Recognising seizure types. Dr Richard Perry. Management of status epilepticus
Emergency epilepsy now what? Dr Richard Perry Imperial College NHS Trust Imperial College Talk outline Recognising seizure types Management of status epilepticus Some definitions Epileptic seizure A clinical
More informationWhat Are the Best Non-IV Parenteral Options for a Seizing Patient? William C. Dalsey, MD, MBA, FACEP
What Are the Best Non-IV Parenteral Options for a Seizing Patient? A 32-year old male intravenous drug user was brought to the ED having had a witnessed generalized tonic-clonic seizure 10 minutes prior
More informationTom Heaps Consultant Acute Physician
Tom Heaps Consultant Acute Physician 76-year-old male no PMHx witnessed generalized seizure at home ~2min further seizure in ambulance terminated after 5min with IV diazepam 10mg GCS 8 on arrival in ED
More informationInappropriate emergency management of status epilepticus in children contributes to need for intensive care
1584 PAPER Inappropriate emergency management of status epilepticus in children contributes to need for intensive care R F M Chin, L Verhulst, B G R Neville, M J Peters, R C Scott... See end of article
More informationCurrent Trends in Treatment of Status Epilepticus and Refractory Status Epilepticus
621 Current Trends in Treatment of Status Epilepticus and Refractory Status Epilepticus John P. Betjemann, MD 1 1 Department of Neurology, University of California, San Francisco, California Semin Neurol
More informationTreatment outcome of status epilepticus in Thammasat University Hospital, Thailand
Neurology Asia 2014; 19(3) : 257 262 Treatment outcome of status epilepticus in Thammasat University Hospital, Thailand Kongkiat Kulkantrakorn MD, Weraphan Moonman MD Neurology Division, Department of
More informationOutline. What is a seizure? What is epilepsy? Updates in Seizure Management Terminology, Triage & Treatment
Outline Updates in Seizure Management Terminology, Triage & Treatment Joseph Sullivan, MD! Terminology! Videos of different types of seizures! Diagnostic evaluation! Treatment options! Acute! Maintenance
More informationRESEARCH ARTICLE MIDAZOLAM EFFICACY AND SIDE EFFECTS IN GENERALIZED AND PARTIAL REFRACTORY STATUS EPILEPTICUS IN CHILDREN
RESEARCH ARTICLE MIDAZOLAM EFFICACY AND SIDE EFFECTS IN GENERALIZED AND PARTIAL REFRACTORY STATUS EPILEPTICUS IN CHILDREN M.R. Salehi Omran MD 1, M.R. Edraki MD 2 1. Associate Professor, Pediatric neurologist,
More informationRefractory Seizures. Dr James Edwards EMCORE May 30th 2014
Refractory Seizures Dr James Edwards EMCORE May 30th 2014 Refractory Seizures Seizures are a common presentation to the ED and some patients will have multiple seizures or have a reduced level of consciousness
More information2016 Treatment Algorithm for Generalized Convulsive Status Epilepticus (SE) in adults and children > 40 kg
Yale New Haven Health Department of Pharmacy, Department of Neurology 2016 Treatment Algorithm for Generalized Convulsive Status Epilepticus (SE) in adults and children > 40 kg Guideline, YNHHS Original
More informationEpilepsy and Epileptic Seizures
Epilepsy and Epileptic Seizures Petr Marusič Dpt. of Neurology Charles University, Second Faculty of Medicine Motol University Hospital Diagnosis Steps Differentiation of nonepileptic events Seizure classification
More informationB GÜRBÜZ, F GÜRBÜZ, A CAYIR, A DE. Key words. Introduction
HK J Paediatr (new series) 2016;21:79-85 Evaluation of Aetiological Causes, Clinical Features, Treatment and Prognosis in Patients Diagnosed with and Treated for Status Epilepticus: An Epidemiological
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Absence seizures, 6 in childhood, 95 Adults, seizures and status epilepticus in, management of, 34 35 with first-time seizures. See Seizure(s),
More informationStatus Epilepticus. Mindy M. Messinger, PharmD Clinical Pharmacy Specialist Neurology Texas Children s Hospital. Pediatrics
Status Epilepticus Mindy M. Messinger, PharmD Clinical Pharmacy Specialist Neurology Texas Children s Hospital Objectives Define the various stages of status epilepticus and explain the proposed pathophysiology
More informationSuccessful Use of Therapeutic Hypothermia for Refractory Nonconvulsive Status Epilepticus
Successful Use of Therapeutic Hypothermia for Refractory Nonconvulsive Status Epilepticus Do-Hyung Kim 1, Hye-hoon Kang 1, Minjung Kim 1, Tae-Won Yang 2, Oh-Young Kwon 1, Jung Sook Yeom 3, Bong Su Kang
More informationThe efficacy of intravenous sodium valproate and phenytoin as the first-line treatment in status epilepticus: a comparison study
Tiamkao et al. BMC Neurology 2013, 13:98 RESEARCH ARTICLE Open Access The efficacy of intravenous sodium valproate and phenytoin as the first-line treatment in status epilepticus: a comparison study Somsak
More informationEffects of clobazam for treatment of refractory status epilepticus
Madžar et al. BMC Neurology (2016) 16:202 DOI 10.1186/s12883-016-0724-y RESEARCH ARTICLE Open Access Effects of clobazam for treatment of refractory status epilepticus Dominik Madžar *, Anna Geyer, Ruben
More informationDuration of Therapeutic Coma and Outcome of Refractory Status Epilepticus. Wolfgang Muhlhofer, M.D. Assistant Professor at UAB Epilepsy Center
Duration of Therapeutic Coma and Outcome of Refractory Status Epilepticus Wolfgang Muhlhofer, M.D. Assistant Professor at UAB Epilepsy Center Status Epilepticus Escalation of Treatment 5 to 10 min 10 to
More informationUnit VIII Problem 7 Pharmacology: Principles of Management of Seizure Disorders
Unit VIII Problem 7 Pharmacology: Principles of Management of Seizure Disorders - Terminologies: Anti-convulsants: they are used to control convulsions seen in certain types of epilepsy. Convulsions may
More informationWHOLE LOTTA SHAKIN GOIN ON
WHOLE LOTTA SHAKIN GOIN ON ADAM M. YATES, MD FACEP ASSOCIATE CHIEF OF EMERGENCY SERVICES UPMC MERCY SEIZURE DEFINITIONS Partial(focal) only involves part of the brain General Involves entire brain Simple
More informationNICIS Paris, June Review of Status epilepticus care
NICIS Paris, June 19 2015 Review of Status epilepticus care Andrea O. Rossetti Département des Neurosciences Cliniques Lausanne, Switzerland Disclosure UCB pharma, SAGE Research support Several medications
More informationGeneralized seizures, generalized spike-waves and other things. Charles Deacon MD FRCPC Centre Hospitalier Universitaire de Sherbrooke
Generalized seizures, generalized spike-waves and other things Charles Deacon MD FRCPC Centre Hospitalier Universitaire de Sherbrooke Objectives Give an overview of generalized EEG discharges and seizures
More informationReview of Anticonvulsant Medications: Traditional and Alternative Uses. Andrea Michel, PharmD, CACP
Review of Anticonvulsant Medications: Traditional and Alternative Uses Andrea Michel, PharmD, CACP Objectives Review epidemiology of epilepsy Classify types of seizures Discuss non-pharmacologic and pharmacologic
More informationClassification of Status Epilepticus: A New Proposal Dan Lowenstein, M.D. University of California, San Francisco
Classification of Status Epilepticus: A New Proposal Dan Lowenstein, M.D. University of California, San Francisco for the ILAE Taskforce for Classification of Status Epilepticus: Eugen Trinka, Hannah Cock,
More informationDepartment of Clinical Pharmacy, University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO 6
American Epilepsy Society Guideline Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society Tracy
More informationPeriodic and Rhythmic Patterns. Suzette M LaRoche, MD Mission Health Epilepsy Center Asheville, North Carolina
Periodic and Rhythmic Patterns Suzette M LaRoche, MD Mission Health Epilepsy Center Asheville, North Carolina Continuum of EEG Activity Neuronal Injury LRDA GPDs SIRPIDs LPDs + NCS Burst-Suppression LPDs
More informationChallenges In Treatment of NCSE NCSE. Definition 22/07/56
Challenges In Treatment of NCSE Anannit Visudtibhan, MD. Division of Neurology, Department of Pediatrics, Faculty of Medicine-Ramathibodi Hospital NCSE Definition & Classification Diagnosis Issues in specific
More informationStatus epilepticus (SE) in simple terms is used to describe
58 SUPPLEMENT TO Journal of the association of physicians of india august 2013 VOL. 61 Status Epilepticus Ramshekar Menon *, Ashalatha Radhakrishnan **, Kurupath Radhakrishnan *** Abstract Status epilepticus
More informationImages have been removed from the PowerPoint slides in this handout due to copyright restrictions.
Seizures Seizures & Status Epilepticus Seizures are episodes of disturbed brain activity that cause changes in attention or behavior. Donna Lindsay, MN RN, CNS-BC, CCRN, CNRN Neuroscience Clinical Nurse
More informationErnie Somerville Prince of Wales Hospital EPILEPSY
Ernie Somerville Prince of Wales Hospital EPILEPSY Overview Classification New and old anti-epileptic drugs (AEDs) Neuropsychiatric side-effects Limbic encephalitis Non-drug therapies Therapeutic wishlist
More informationManagement and prognosis of status epilepticus according to hospital setting: a prospective study
Original article Peer reviewed article SWISS MED WKLY 2009;139(49 50):719 723 www.smw.ch 719 Management and prognosis of status epilepticus according to hospital setting: a prospective study Andrea O.
More informationTRENDS AND STRATEGY TOWARDS THERAPIES FOR STATUS EPILEPTICUS: A DECISIVE REVIEW
Review Article TRENDS AND STRATEGY TOWARDS THERAPIES FOR STATUS EPILEPTICUS: A DECISIVE REVIEW Setu Gupta 1 *, Avinash Laddha 1, Piyush Chaturvedi 1, Nupur Chaturvedi 1, Amlan Mishra 2, Raghvendra 3 1
More informationClinical Study Underestimated Rate of Status Epilepticus according to the Traditional Definition of Status Epilepticus
e Scientific World Journal Volume 2015, Article ID 801834, 5 pages http://dx.doi.org/10.1155/2015/801834 Clinical Study Underestimated Rate of Status Epilepticus according to the Traditional Definition
More informationStatus epilepticus. Can the incidence be reduced? ABSTRACT
Original Articles Status epilepticus Can the incidence be reduced? Jumana Y. Al-Aama, RCP(UK), SSC, Ali O. Shaabat, BChB, RCSC. ABSTRACT Objectives: To identify high risk groups for the development of
More informationSeizure 18 (2009) Contents lists available at ScienceDirect. Seizure. journal homepage:
Seizure 18 (2009) 38 42 Contents lists available at ScienceDirect Seizure journal homepage: www.elsevier.com/locate/yseiz Non-convulsive status epilepticus; the rate of occurrence in a general hospital
More informationShands Jacksonville Department of Pharmacy
Shands Jacksonville Department of Pharmacy Medication Use Evaluation: IV Levetiracetam Evaluation Time Period: 05/27/2013 06/24/2013 Important Aspect of Care: Care of Patients, Medication Use, Prescribing
More informationSeizure 20 (2011) Contents lists available at ScienceDirect. Seizure. journal homepage:
Seizure 20 (2011) 60 64 Contents lists available at ScienceDirect Seizure journal homepage: www.elsevier.com/locate/yseiz Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus:
More informationNeurological Prognosis after Cardiac Arrest Guideline
Neurological Prognosis after Cardiac Arrest Guideline I. Associated Guidelines and Appendices 1. Therapeutic Hypothermia after Cardiac Arrest 2. Hypothermia after Cardiac Arrest Algorithm II. Rationale
More informationGuideline of status epilepticus management 2017
Guideline of status epilepticus management 2017 Kanitpong Phabphal Professor of Neurology Guideline 1966 to Jan 2005 European Foundation Neurology Society 2010 Hong Kong Epilepsy Society Society 2017 Published
More informationTreatment of Pediatric Status Epilepticus Tobias Loddenkemper, MD 1,* Howard P. Goodkin, MD, PhD 2
Current Treatment Options in Neurology (2011) 13:560 573 DOI 10.1007/s11940-011-0148-3 Pediatric Neurology (Harvey S. Singer, Section Editor) Treatment of Pediatric Status Epilepticus Tobias Loddenkemper,
More informationSimple Protocol & Bayesian Design: Established Status Epilepticus Treatment Trial (ESETT)
Simple Protocol & Bayesian Design: Established Status Epilepticus Treatment Trial (ESETT) Jaideep Kapur on behalf of ESETT invertigator University of Virginia Status epilepticus is a condition resulting
More informationTypes of Status Epilepticus: Definitions and Classification
Types of Status Epilepticus: Definitions and Classification 2 Eugen Trinka Introduction Status epilepticus (SE) is often referred to the maximum expression of epilepsy. It is also a very severe expression
More informationGoals for sedation during mechanical ventilation
New Uses of Old Medications Gina Riggi, PharmD, BCCCP, BCPS Clinical Pharmacist Trauma ICU Jackson Memorial Hospital Disclosure I do not have anything to disclose Objectives Describe the use of ketamine
More informationAET Symposium Management of Refractory Status Epilepticus December 1, 2012
AET Symposium Management of Refractory Status Epilepticus December 1, 2012 Aristea S. Galanopoulou, MD PhD Albert Einstein College of Medicine, Bronx NY USA American Epilepsy Society Annual Meeting Disclosure
More informationProposed practical working definitions of NORSE, FIRES, related syndromes, and Status Epilepticus (SE) of different severities: consensus panel
Proposed practical working definitions of NORSE, FIRES, related syndromes, and Status Epilepticus (SE) of different severities: consensus panel 5 April 2017 Hotel Imlauer Salzburg Austria Objective To
More informationSuper-refractory status epilepticus (SRSE), or seizures. Pediatric Super-Refractory Status Epilepticus Treated with Allopregnanolone
BRIEF COMMUNICATION Pediatric Super-Refractory Status Epilepticus Treated with Allopregnanolone Eileen Broomall, MD, 1 JoAnne E. Natale, MD, 2 Michele Grimason, APN, 1 Joshua Goldstein, MD, 1 Craig M.
More information0 56 BiPLEDS 3 (L:2, O:1), 9
Supplementary Table 1. Demographics and clinical characteristics of the patients. CSF Sex/Age Prodrome CSF WBC Protein Patient 1 M/23 Patient 2 M/20 Patient 3 F/27 Patient 4 F/38 3 days headache, 1 day
More informationStatus Epilepticus in Children
Medical Emergency Status Epilepticus in Children Col M K Behera *, Lt Col K S Rana +, Lt Col M Kanitkar #, Surg Cdr K M Adhikari ** Abstract Status epilepticus (SE) is a life-threatening emergency that
More informationStatus Epilepticus: The good, the bad, the ugly
Status Epilepticus: The good, the bad, the ugly Emily J. Gilmore, MD, MS Assistant Professor Division of Neurocritical Care and Emergency Neurology, and Epilepsy (CCEEG) Yale New Haven Hospital/Yale School
More informationImpact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus
Madžar et al. Critical Care (218) 22:317 https://doi.org/1.1186/s1354-18-2235-2 RESEARCH Open Access Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status
More informationA comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus
Q J Med 2002; 95:225 231 A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus H.R. COCK 1 and A.H.V. SCHAPIRA 1,2 From the 1 Department of Clinical and Experimental
More informationAntiepileptic agents
Antiepileptic agents Excessive excitability of neurons in the CNS Abnormal function of ion channels Spread through neural networks Abnormal neural activity leads to abnormal motor activity Suppression
More informationIn our patients the cause of seizures can be broadly divided into structural and systemic causes.
Guidelines for the management of Seizures Amalgamation and update of previous policies 7 (Seizure guidelines, ND, 2015) and 9 (Status epilepticus, KJ, 2011) Seizures can occur in up to 15% of the Palliative
More informationOn completion of this chapter you should be able to: list the most common types of childhood epilepsies and their symptoms
9 Epilepsy The incidence of epilepsy is highest in the first two decades of life. It falls after that only to rise again in late life. Epilepsy is one of the most common chronic neurological condition
More information